최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Radiochimica acta, v.106 no.10, 2018년, pp.851 - 855
Bolla, R. Sekhar (Department of Chemistry, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur Dist, India) , Gulipalli, Kali Charan (Department of Chemistry, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur Dist, India) , Gandikota, N. Murthy (Department of Chemistry, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur Dist, India) , Bodige, Srinu , Viswanath, I. V. Kasi
AbstractSildenfil a vasodilating agent is a selective inhibitor of cyclic guanosine monophosphate - specific phosphodiesterase type 5 which is used for the treatment of male erectile dysfunction and pulmonary arterial hypertension. We presented a detailed approach for the synthesis of [2H3]sildenafi...
10.1016/0960-894X(96)00323-X Terrett, N. K., Bell, A. S.: Sildenafil (VIAGRA™), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction. Bioorganic Med. Chem. Lett. 6(15), 1819 (1996).
10.1016/S0002-9149(99)00044-2 Webb, D. J., Freestone, S.: Sildenafil citrate and blood- pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am. J. Cardiol. 83(5 Suppl 1), 2 (1999).
10.1038/nature01914 Hwang, K. Y., Ro, S.: Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules. Nature 425, 98 (2003).
10.1016/j.rmed.2014.01.003 Liang, Z.-A., Wang, R.-C.: Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review. Respir. Med. 108, 531 (2014).
10.1021/op9900683 Dale, D. J., Dunn, P. J., Hughes, M. L.: The chemical development of the commercial route to sildenafil: a case history. Org. Process Res. Dev. 4, 17 (2000).
10.1021/op040019c Dunn, P. J.: Synthesis of commercial phosphodiesterase(V) inhibitors. Org Process Res. Dev. 9, 88 (2005).
Bell, A. S., Sandwich, K.: Pyrazolopyrimidinone antianginal agents, EP0463756 (1992).
Czarnik, A. W., Reno: Deuterium enriched Sildenafil, US2009/0062298 (2009).
10.1055/s-0031-1296622 Schneider, F., Mattern-Dogru, E., Hillgenberg, M., Alken, R. G.: Changed phosphodiesterase selectivity and enhanced in vitro efficacy by selective deuteration of Sildenafil. Arzneimittelforschung 57(6), 293 (2007).
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.